Immunity and vaccine development efforts against Trypanosoma cruzi

被引:47
作者
Rios, Lizette E. [1 ]
Carlos Vazquez-Chagoyan, Juan [2 ]
Ortega Pacheco, Antonio [3 ]
Paola Zago, M. [4 ]
Garg, Nisha J. [1 ,5 ]
机构
[1] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[2] Univ Autonoma Estado Mexico, Fac Med Vet & Zootecnia, Ctr Invest & Estudios Avanzados Salud Anim, Toluca, Mexico
[3] Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Dept Salud Anim & Med Prevent, Merida, Yucatan, Mexico
[4] Univ Nacl Salta, Inst Patol Expt, CONICET, Salta, Argentina
[5] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA
基金
美国国家卫生研究院;
关键词
Chagas; Prophylactic; Therapeutic; Vaccine; Immunity; Adjuvants; COMPLEMENT REGULATORY PROTEIN; PARAFLAGELLAR ROD PROTEINS; THERAPEUTIC DNA VACCINE; CHRONIC CHAGAS-DISEASE; TERT-BUTYL-NITRONE; TRANS-SIALIDASE; GENETIC IMMUNIZATION; PROTECTIVE IMMUNITY; OXIDATIVE STRESS; MITOCHONDRIAL DYSFUNCTION;
D O I
10.1016/j.actatropica.2019.105168
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Trypanosoma cruzi (T. cruzi) is the causative agent for Chagas disease (CD). There is a critical lack of methods for prevention of infection or treatment of acute infection and chronic disease. Studies in experimental models have suggested that the protective immunity against T. cruzi infection requires the elicitation of Th1 cytokines, lytic antibodies and the concerted activities of macrophages, T helper cells, and cytotoxic T lymphocytes (CTLs). In this review, we summarize the research efforts in vaccine development to date and the challenges faced in achieving an efficient prophylactic or therapeutic vaccine against human CD.
引用
收藏
页数:11
相关论文
共 156 条
[41]   gp63 homologues in Trypanosoma cruzi:: Surface antigens with metalloprotease activity and a possible role in host cell infection [J].
Cuevas, IC ;
Cazzulo, JJ ;
Sánchez, DO .
INFECTION AND IMMUNITY, 2003, 71 (10) :5739-5749
[42]   Monitoring the parasite load in chronic Chagas disease patients: comparison between blood culture and quantitative real time PCR [J].
D'Avila, Daniella Alchaar ;
Galvao, Lucia Maria C. ;
Sousa, Giovane R. ;
Britto, Constanca ;
Moreira, Otacilio C. ;
Chiari, Egler .
PLOS ONE, 2018, 13 (11)
[43]   Theft and Reception of Host Cell's Sialic Acid: Dynamics of Trypanosoma Cruzi Trans-sialidases and Mucin-Like Molecules on Chagas' Disease Immunomodulation [J].
da Fonseca, Leonardo Marques ;
da Costa, Kelli Monteiro ;
Chaves, Victoria de Sousa ;
Freire-de-Lima, Celio Geraldo ;
Morrot, Alexandre ;
Mendonca-Previato, Lucia ;
Previato, Jose Osvaldo ;
Freire-de-Lima, Leonardo .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[44]  
DAlmeida P, 1996, TRANSPLANT P, V28, P93
[45]   Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins -: Implications in Chagas' disease [J].
Dhiman, Monisha ;
Nakayasu, Ernesto Satoshi ;
Madaiah, Yashoda Hosakote ;
Reynolds, Brobey K. ;
Wen, Jian-jun ;
Almeida, Igor Correia ;
Garg, Nisha Jain .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (03) :728-740
[46]   MnSODtg Mice Control Myocardial Inflammatory and Oxidative Stress and Remodeling Responses Elicited in Chronic Chagas Disease [J].
Dhiman, Monisha ;
Wan, Xianxiu ;
Popov, Vsevolod L. ;
Vargas, Gracie ;
Garg, Nisha Jain .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2013, 2 (05)
[47]   Cardiac-Oxidized Antigens Are Targets of Immune Recognition by Antibodies and Potential Molecular Determinants in Chagas Disease Pathogenesis [J].
Dhiman, Monisha ;
Paola Zago, Maria ;
Nunez, Sonia ;
Amoroso, Alejandro ;
Rementeria, Hugo ;
Dousset, Pierre ;
Nunez Burgos, Federico ;
Garg, Nisha Jain .
PLOS ONE, 2012, 7 (01)
[48]   Increased Myeloperoxidase Activity and Protein Nitration Are Indicators of Inflammation in Patients with Chagas' Disease [J].
Dhiman, Monisha ;
Estrada-Franco, Jose Guillermo ;
Pando, Jasmine M. ;
Ramirez-Aguilar, Francisco J. ;
Spratt, Heidi ;
Vazquez-Corzo, Sara ;
Perez-Molina, Gladys ;
Gallegos-Sandoval, Rosa ;
Moreno, Roberto ;
Garg, Nisha Jain .
CLINICAL AND VACCINE IMMUNOLOGY, 2009, 16 (05) :660-666
[49]   Cell-mediated immunity in experimental Trypanosoma cruzi infection [J].
DosReis, GA .
PARASITOLOGY TODAY, 1997, 13 (09) :335-342
[50]   Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice [J].
Dumonteil, E ;
Escobedo-Ortegon, J ;
Reyes-Rodriguez, N ;
Arjona-Torres, A ;
Ramirez-Sierra, MJ .
INFECTION AND IMMUNITY, 2004, 72 (01) :46-53